-
#Generics and inner classes are important core concepts from@Java and that's what this challenger is about!#JavaChallengers Can you get it right?https://www.youtube.com/watch?v=JtR-fWeHWH0 … -
Thanks to our partners Dirt Media, Model B and
@RedPegMarketing for helping us celebrate the 35th birthday of#generics in award-winning style!#hb2genericshttps://twitter.com/PACouncil/status/1225104658181439490 … -
Update your knowledge on marketing authorization procedures with Dr. Helmut Vigenschow, an expert with 30 years of experience in the pharma industry. Download the event brochure to see the detailed program at: https://tinyurl.com/vut3ecn
#generics#flemingtrainings#barcelonapic.twitter.com/PSIbIkI98H
-
How are originator and
#generics industries diverging and to what extent to innovators want to play in the hybrid space? Download this article to find out http://bit.ly/2RwmLh6 pic.twitter.com/jqLkiCg0W0
-
World Cancer Day February 4 supports
@ASCO,@ACCCBuzz,@AmCollegeGastro,@OncologyNursing and patients with#cancer.#DYK that#generics saved the U.S. health care system $11.4B on#cancer treatments in 2018?#GRxBiosimsSavingsReport#WorldCancerDay
pic.twitter.com/rZlKOhIsT6
-
Global branded
#generics sales to expand at 8% CAGR through 2029 https://www.thepharmaletter.com/article/global-branded-generics-sales-to-expand-at-8-cagr-through-2029 … -
Sandoz completes acquisition of Aspen’s Japanese operations, strengthening its position in world’s third largest market for generics and off-patent medicines https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-aspen%27s-japanese-operations-strengthening-its-position-world%27s-third-largest-market-generics-and-patent-medicines …
#BreakingNewsPharma#pharmanews#breakingnews#sandoz#aspen#generics#patent#medicinespic.twitter.com/dGPiMVjrQr
-
Competition between
#generics and originators - what’s the relevance of a#patent?(Part II) | Lexology https://buff.ly/3bc4DAL -
Download this summary of our latest roundtable event featuring senior
#pharma industry executives and find out more about the future of#generics. http://bit.ly/38VV1Zh pic.twitter.com/6mR47kqOR4
-
Now recruiting for a Head Global Portfolio (d/f/m) at Sandoz. This is a great opportunity to shape the portfolio and pipeline of a global leader in
#generics. https://lnkd.in/dDr9ZuK -
Novartis tips complex manufacturing to insulate Sandostatin from
#generics https://buff.ly/3b8gboL -
#patent#oncology#generics While Russian authorities support russian generics, oncologist ask for original drugs for their patients. Because onco-generics do nothing... https://pharmvestnik.ru/articles/Pro-rak-v-svoem-otechestve.html … -
No.. this is why I get generic goobers.
#MrPeanut#generics#smhhttps://twitter.com/MrPeanut/status/1224156970426474496 …
-
.
@US_FDA revises ANDA prioritization MAPP https://www.thepharmaletter.com/article/fda-revises-anda-prioritization-mapp …#generics -
EU Court ruling in pay-for-delay drug case https://www.thepharmaletter.com/article/eu-court-ruling-in-pay-for-delay-drug-case …
#generics -
The availability of safe, effective and affordable
#generics produces tremendous savings for America’s patients. Learn more: http://bit.ly/GRxBiosimsSavingsReport …#GRxBiosimsSavingsReport#genericdrugs#health#patientsavingspic.twitter.com/Xlf5MmSzOm
-
PharmaScrip: The battle lines are starting to blur between
#BigPharma &#Generics & could this competitor industry be a potential partner? Find out in this article here http://bit.ly/2GwBSRs pic.twitter.com/PyBjtC0W7l http://dlvr.it/RP2Cw8 pic.twitter.com/aN1I0g5MCq
-
-
Amid a tough operating environment for
#generics, many other players are reconsidering whether they want to compete at often minimal profit margins. Learn more here http://bit.ly/2tNMR6i pic.twitter.com/65GMoCiWAM
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.